9-128322905-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016035.5(COQ4):āc.47C>Gā(p.Pro16Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,596,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_016035.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COQ4 | NM_016035.5 | c.47C>G | p.Pro16Arg | missense_variant | 1/7 | ENST00000300452.8 | NP_057119.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ4 | ENST00000300452.8 | c.47C>G | p.Pro16Arg | missense_variant | 1/7 | 1 | NM_016035.5 | ENSP00000300452 | P1 | |
COQ4 | ENST00000372875.3 | c.47C>G | p.Pro16Arg | missense_variant | 1/4 | 2 | ENSP00000361966 | |||
COQ4 | ENST00000608951.5 | c.47C>G | p.Pro16Arg | missense_variant | 1/3 | 2 | ENSP00000476323 | |||
COQ4 | ENST00000609948.1 | c.47C>G | p.Pro16Arg | missense_variant | 1/2 | 2 | ENSP00000477292 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152250Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000331 AC: 7AN: 211356Hom.: 0 AF XY: 0.0000169 AC XY: 2AN XY: 118014
GnomAD4 exome AF: 0.0000208 AC: 30AN: 1444112Hom.: 0 Cov.: 30 AF XY: 0.0000195 AC XY: 14AN XY: 718180
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74376
ClinVar
Submissions by phenotype
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2022 | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 16 of the COQ4 protein (p.Pro16Arg). This variant is present in population databases (rs775518369, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with COQ4-related conditions. ClinVar contains an entry for this variant (Variation ID: 476183). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 24, 2024 | The c.47C>G (p.P16R) alteration is located in exon 1 (coding exon 1) of the COQ4 gene. This alteration results from a C to G substitution at nucleotide position 47, causing the proline (P) at amino acid position 16 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at